Today, on the national holiday, King Philippe awards the honorary title of …
MEMBER NEWS: RIP project by Prof. Dr. Eric Cox and Prof. Dr. Bert Devriendt
The Industrial Research Fund (IOF) has recently approved funding for the pioneering …
OPEN CALLS from Inno4Vac and TRANSVAC
Inno4Vac is calling for proposals in: Systems immunology Bio-manufacturing modelling. Proposals can receive …
MEMBER NEWS: AstriVax enters clinical phase with its novel vaccine platform technology
We are thrilled to announce that AstriVax, a member of Flanders Vaccine, …
Virologists hold their breath for bird flu
In the US, bird flu is sweeping through dairy farms. Experts are …
What’s behind the surge in measles cases?
Measles are on the rise again. Countries across the globe are facing …
Patient immunomonitoring (PIM) in infectious diseases
Field laboratory preparedness Are you a biomedical scientist or professional with an …
Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study
Our member, Cerba Research (formerly known as Viroclinics-DDL), has published a new …
European Commission secures human avian flu vaccines
The European Commission has secured new human vaccine doses for member states …
White paper: New delivery methods in the fight against vaccine-preventable diseases?
We are excited to share that our member, IDEVAX, has released a …